Kilitch Drugs (India) Limited has informed the Exchange regarding 'Postponement in Finalization of Basis of Allotment and Allotment Schedule for Rights Issue '.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs has postponed the finalization of basis of allotment and the allotment process for its Rights Issue from the originally scheduled date of August 22, 2025 to August 25, 2025, citing coordination with NSE (the designated stock exchange) and the Registrar to the Issue. The Rights Issue involves 13,98,463 equity shares at Rs. 357 per share, aggregating approximately Rs. 49.93 crores, in the ratio of 2 rights shares for every 23 fully paid-up shares held, with the record date having been July 15, 2025. The Board had approved the Letter of Offer on July 12, 2025. This is a short procedural delay of three days, not a structural change to the issue.
Existing eligible shareholders retain their entitlement under the same terms (2 rights shares for every 23 held at Rs. 357 each). The three-day delay is administrative and unlikely to materially affect shareholders or the stock price, provided allotment proceeds on the revised date without further issues.